|
1
|
Anders HJ, Saxena R, Zhao MH, Parodis I,
Salmon JE and Mohan C: Lupus nephritis. Nat Rev Dis Primers.
6(7)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Stokes MB and D'Agati VD: Classification
of lupus nephritis: Time for a change? Adv Chronic Kidney Dis.
26:323–329. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Davidson A, Aranow C and Mackay M: Lupus
nephritis: Challenges and progress. Curr Opin Rheumatol.
31:682–688. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Song K, Liu L, Zhang X and Chen X: An
update on genetic susceptibility in lupus nephritis. Clin Immunol.
210(108272)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Yang X, Yao G, Chen W, Tang X, Feng X and
Sun L: Exacerbation of lupus nephritis by high sodium chloride
related to activation of SGK1 pathway. Int Immunopharmacol.
29:568–573. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Frangou E, Georgakis S and Bertsias G:
Update on the cellular and molecular aspects of lupus nephritis.
Clin Immunol. 216(108445)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Tang Y, Zhang W, Zhu M, Zheng L, Xie L,
Yao Z, Zhang H, Cao D and Lu B: Lupus nephritis pathology
prediction with clinical indices. Sci Rep. 8(10231)2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Trinchieri G: Interleukin-12 and the
regulation of innate resistance and adaptive immunity. Nat Rev
Immunol. 3:133–146. 2003.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Kang BY, Kim E and Kim TS: Regulatory
mechanisms and their therapeutic implications of interleukin-12
production in immune cells. Cell Signal. 17:665–673.
2005.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ma CS, Suryani S, Avery DT, Chan A, Nanan
R, Santner-Nanan B, Deenick EK and Tangye SG: Early commitment of
naïve human CD4(+) T cells to the T follicular helper (T(FH)) cell
lineage is induced by IL-12. Immunol Cell Biol. 87:590–600.
2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Teng MWL, Bowman EP, McElwee JJ, Smyth MJ,
Casanova JL, Cooper AM and Cua DJ: IL-12 and IL-23 cytokines: From
discovery to targeted therapies for immune-mediated inflammatory
diseases. Nat Med. 21:719–729. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Sandborn WJ, Gasink C, Gao LL, Blank MA,
Johanns J, Guzzo C, Sands BE, Hanauer SB, Targan S, Rutgeerts P, et
al: CERTIFI Study Group: Ustekinumab induction and maintenance
therapy in refractory Crohn's disease. N Engl J Med. 367:1519–1528.
2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Vom Berg J, Prokop S, Miller KR, Obst J,
Kälin RE, Lopategui-Cabezas I, Wegner A, Mair F, Schipke CG, Peters
O, et al: Inhibition of IL-12/IL-23 signaling reduces Alzheimer's
disease-like pathology and cognitive decline. Nat Med.
18:1812–1819. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Ueno H: The IL-12-STAT4 axis in the
pathogenesis of human systemic lupus erythematosus. Eur J Immunol.
50:10–16. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Huang X, Hua J, Shen N and Chen S:
Dysregulated expression of interleukin-23 and interleukin-12
subunits in systemic lupus erythematosus patients. Mod Rheumatol.
17:220–223. 2007.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Hochberg MC: Updating the American College
of Rheumatology revised criteria for the classification of systemic
lupus erythematosus. Arthritis Rheum. 40:1725–1726. 1997.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Weening JJ, D'Agati VD, Schwartz MM,
Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T,
Ferrario F, et al: International Society of Nephrology Working
Group on the Classification of Lupus Nephritis; Renal Pathology
Society Working Group on the Classification of Lupus Nephritis: The
classification of glomerulonephritis in systemic lupus
erythematosus revisited. Kidney Int. 65:521–530. 2004.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Li W, Titov AA and Morel L: An update on
lupus animal models. Curr Opin Rheumatol. 29:434–441.
2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yao G, Qi J, Zhang Z, Huang S, Geng L, Li
W, Chen W, Tang X, Wang S and Sun L: Endothelial cell injury is
involved in atherosclerosis and lupus symptoms in
gld.apoE-/- mice. Int J Rheum Dis. 22:488–496.
2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-∆ ∆ C(T)) Method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Larosa M, Zen M, Gatto M, Jesus D, Zanatta
E, Iaccarino L, Inês L and Doria A: IL-12 and IL-23/Th17 axis in
systemic lupus erythematosus. Exp Biol Med (Maywood). 244:42–51.
2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zundler S and Neurath MF: Interleukin-12:
Functional activities and implications for disease. Cytokine Growth
Factor Rev. 26:559–568. 2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Trembleau S, Penna G, Gregori S,
Giarratana N and Adorini L: IL-12 administration accelerates
autoimmune diabetes in both wild-type and IFN-gamma-deficient
nonobese diabetic mice, revealing pathogenic and protective effects
of IL-12-induced IFN-gamma. J Immunol. 170:5491–5501.
2003.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Smith T, Hewson AK, Kingsley CI, Leonard
JP and Cuzner ML: Interleukin-12 induces relapse in experimental
allergic encephalomyelitis in the Lewis rat. Am J Pathol.
150:1909–1917. 1997.PubMed/NCBI
|
|
25
|
Constantinescu CS, Wysocka M, Hilliard B,
Ventura ES, Lavi E, Trinchieri G and Rostami A: Antibodies against
IL-12 prevent superantigen-induced and spontaneous relapses of
experimental autoimmune encephalomyelitis. J Immunol.
161:5097–5104. 1998.PubMed/NCBI
|
|
26
|
McIntyre KW, Shuster DJ, Gillooly KM,
Warrier RR, Connaughton SE, Hall LB, Arp LH, Gately MK and Magram
J: Reduced incidence and severity of collagen-induced arthritis in
interleukin-12-deficient mice. Eur J Immunol. 26:2933–2938.
1996.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Malfait AM, Butler DM, Presky DH, Maini
RN, Brennan FM and Feldmann M: Blockade of IL-12 during the
induction of collagen-induced arthritis (CIA) markedly attenuates
the severity of the arthritis. Clin Exp Immunol. 111:377–383.
1998.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Talaat RM, Mohamed SF, Bassyouni IH and
Raouf AA: Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus
erythematosus (SLE) patients: Correlation with disease activity.
Cytokine. 72:146–153. 2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Lauwerys BR, Van Snick J and Houssiau FA:
Serum IL-12 in systemic lupus erythematosus: Absence of p70
heterodimers but presence of p40 monomers correlating with disease
activity. Lupus. 11:384–387. 2002.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Segal R, Dayan M, Zinger H, Habut B,
Shearer GM and Mozes E: The effect of IL-12 on clinical and
laboratory aspects of experimental SLE in young and aging mice. Exp
Gerontol. 38:661–668. 2003.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Neumann D, Tschernig T, Popa D, Schmiedl
A, Pérez de Lema G, Resch K and Martin MU: Injection of IL-12- and
IL-18-encoding plasmids ameliorates the autoimmune pathology of
MRL/Mp-Tnfrsf6lpr mice: Synergistic effect on autoimmune symptoms.
Int Immunol. 18:1779–1787. 2006.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kikawada E, Lenda DM and Kelley VR: IL-12
deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal
IFN-γ expression, and diminishes systemic pathology. J Immunol.
170:3915–3925. 2003.PubMed/NCBI View Article : Google Scholar
|
